Atlas Trials

Randomized Study of Plasma ctDNA Methylation to Guide Adjuvant Chemotherapy Decisions in High-Risk T3N0 Colorectal Cancer

Clinical trial NCT07562711 · RECRUITING

Trial details

NCT number
NCT07562711
Sponsor
Fudan University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
ctDNAChemotherapyColorectal Cancer
Start date
2024-11-01
Primary completion
2027-12-31
Enrollment
340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.